The Wyss Center receives ISO 13485 Certification by TÜV SÜD for its Quality Management System

Wyss Center appoints Dr. Craig Cook as new Head of Business Development and Licensing

Wyss Center partners with ALBA network

The Wyss Center partners with the ALBA Network to raise awareness and advocate for increased equity, inclusion and visibility of scientists from underrepresented groups in brain research.

Wyss Center Geneva appoints Erwin Böttinger as new Chief Executive Officer

The appointment follows a funding commitment of CHF 120 million from the Wyss Foundation to further strengthen the Center’s mission to accelerate innovative therapies to the clinic to transform the lives of people with brain disorders.

New project: InnerVoice

A new Wyss Center - University of Geneva collaboration aims to decode imagined speech directly from the brain using novel implanted electrodes and new algorithms.

New project: Repairing the spinal cord

Gene therapy to boost rehabilitation success following spinal cord injury.

New project: STAR - Solutions Through Astrocyte Research

The STAR team is pursuing new strategies, focused on astrocytes, to identify biomarkers and new therapeutic targets to treat neurological and psychiatric disorders.

Brain-computer interfaces: New technology. More data. Improving lives.

Symposium: As the BCI community shifts its focus to clinical studies for patient benefit, join us to hear from researchers and companies working together at the forefront of BCI development discussing paths to translation and BCI home-use.

In conversation with Jules Scholler, PhD, Software Engineer in Bioimaging

Software Engineer in Bioimaging, Jules Scholler, describes what it's like to work at the boundary of biology, optics and computer science. The ‘in conversation’ series features members of the Wyss Center community discussing their work, their collaborations and imagining the future.

Latest neural signals recorded with ABILITY brain-computer interface and new details of the system presented at Society for Neuroscience meeting

Wyss Center’s ABILITY system, designed to improve quality of life and independence for people with severe paralysis, demonstrates safety and efficacy in pre-clinical trials.